H. Lundbeck A/S
HLUN-A
शेयरों में रैंक
#3067
H. Lundbeck A/S engages in the research, development, manufacturing, and... H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat major depressive disorder and schizophrenia; Vyepti for migraine prevention; and Cipralex/Lexapro for depression. It also provides Northera for symptomatic neurogenic orthostatic hypotension; Onfi for epilepsy; Sabril for refractory complex partial seizures and infantile spasms; Ebixa for dementia, Azilect for Parkinson’s disease; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol for psychosis. In addition, the company develops Eptinezumab for migraine prevention; Eptinezumab, which is in phase 3 clinical trial for cluster headache; Lu AG09222, which is in phase 2 clinical trial for migraine prevention; Lu AG13909 that is in phase 1 clinical trial for neurohormonal dysfunctions; Brexpiprazole for post-traumatic stress disorder; Lu AF28996, which is in phase 1 clinical trial for Parkinson’s disease; MAGLi program that is in phase 1 clinical trial for neurology; Bexicaserin, which is in phase 3 clinical trial for developmental and epileptic encephalopathies; Amlenetug that is in phase 3 clinical trial for synucleinopathies; and Lu AG22515, which is in clinical phase 1 clinical trial for neurology. Lundbeck A/S has a strategic research collaboration with Contera Pharma to develop oligonucleotide-based medicines for patients living with serious neurological conditions. The company was founded in 1915 and is headquartered in Valby, Denmark.
शेयर मूल्य
$7.07
अंतिम समन्वयन: 2026-10-21
मार्केट कैप
$5.91B
बदलाव (1 दिन)
-4.56%
बदलाव (1 वर्ष)
27.71%
देश
DK
व्यापार H. Lundbeck A/S (HLUN-A)
श्रेणी
Healthcare
H. Lundbeck A/S (HLUN-A) के लिए स्टॉक विभाजन इतिहास
H. Lundbeck A/S स्टॉक (प्रतीक: HLUN-A) में कुल 0 स्टॉक विभाजन हुए।
सबसे हाल का स्टॉक विभाजन Oct 22, 2026 को हुआ।
Oct 22, 2026 से पहले खरीदा गया एक HLUN-A शेयर अब 0 HLUN-A शेयरों के बराबर होगा।
सबसे हाल का स्टॉक विभाजन Oct 22, 2026 को हुआ।
Oct 22, 2026 से पहले खरीदा गया एक HLUN-A शेयर अब 0 HLUN-A शेयरों के बराबर होगा।
स्टॉक विभाजन सूची
| वर्ष | विभाजन | गुणक | संचयी गुणक |
|---|---|---|---|
| प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं। | |||
समान कंपनियों या प्रतिस्पर्धियों के लिए स्टॉक विभाजन
| कंपनी | स्टॉक विभाजनों की संख्या | संचयी गुणक | देश |
|---|---|---|---|
| 0 | - |
US
|
|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
US
|
|
| 0 | - |
IT
|
